SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-002134
Filing Date
2023-02-08
Accepted
2023-02-08 16:06:25
Documents
54
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 10-Q enta-20221231.htm   iXBRL 10-Q 1806213
2 EX-31.1 enta-ex31_1.htm EX-31.1 13732
3 EX-31.2 enta-ex31_2.htm EX-31.2 13723
4 EX-32.1 enta-ex32_1.htm EX-32.1 15745
5 GRAPHIC img215141716_0.jpg GRAPHIC 125141
  Complete submission text file 0000950170-23-002134.txt   7261679

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT enta-20221231.xsd EX-101.SCH 36648
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT enta-20221231_lab.xml EX-101.LAB 349429
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT enta-20221231_pre.xml EX-101.PRE 269536
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT enta-20221231_def.xml EX-101.DEF 143369
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT enta-20221231_cal.xml EX-101.CAL 42374
48 EXTRACTED XBRL INSTANCE DOCUMENT enta-20221231_htm.xml XML 1482343
Mailing Address 500 ARSENAL STREET WATERTOWN MA 02472
Business Address 500 ARSENAL STREET WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Filer) CIK: 0001177648 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-35839 | Film No.: 23599095
SIC: 2834 Pharmaceutical Preparations